Paroxetine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 62175-472

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine Hydrochloride (NDC 62175-472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Paroxetine Extended Release Tablets Usp 1)

Chemical structure diagram of Paroxetine Hydrochloride, showing its molecular configuration with distinct ring systems and substituents, including a fluorine atom and hydrochloride moiety.*

FDA Label Image

12.5 mg 30 Count Bottle Label (Paroxetine Extended Release Tablets Usp 2)

A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC of interacting drugs Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.0.*

FDA Label Image

25 mg 30 Count Bottle Label (Paroxetine Extended Release Tablets Usp 3)

A scatter plot with error bars showing fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for Paroxetine Hydrochloride interacting with various drugs. The x-axis represents change relative to reference, and the y-axis lists interacting drugs with corresponding dosages: Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam.*

FDA Label Image

37.5 mg 30 Count Bottle Label (Paroxetine Extended Release Tablets Usp 4)

A pharmacokinetic chart showing fold changes and 90% confidence intervals in parameters Cmax, Cmin, and AUC for Paroxetine Hydrochloride across different populations. The groups include renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years at various doses, and gender (males). The x-axis represents change relative to reference values on a logarithmic scale from 0.5 to 50.*

FDA Label Image

Paroxetine Extended Release Tablets Usp 5

Label for Paroxetine Extended-Release Tablets, USP 12.5 mg film-coated tablets. The label includes storage instructions, dosing advisories, and safety warnings. It is distributed by Lannett Company, Inc., Philadelphia, PA, and contains 30 tablets. The label features dosage strength prominently and provides a website for medication guides.*

FDA Label Image

Paroxetine Extended Release Tablets Usp 6

Label for Paroxetine Extended-Release Tablets, USP 25 mg, film-coated tablets by Lannett Company, Inc. The label specifies storage instructions, dosage form, and includes a barcode. The package contains 30 tablets and indicates prescription use only.*

FDA Label Image

Paroxetine Extended Release Tablets Usp 7

Label for Paroxetine Extended-Release Tablets, USP 37.5 mg, film-coated extended-release oral tablets. The label specifies storage instructions at 20°C to 25°C, a note to swallow tablets whole without chewing or crushing, and indicates the packaging contains 30 tablets. Distributed by Lannett Company, Inc., Philadelphia, PA, the label includes an NDC code and references prescribing information guiding dosage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.